|
🐜
|
miR-34a as part of the resistance network in chronic lymphocytic leukemia.
12 auth.
T. Zenz,
J. Mohr,
E. Eldering,
A. Kater,
A. Bühler,
D. Kienle,
...
D. Winkler,
J. Dürig,
M. V. van Oers,
D. Mertens,
H. Döhner,
S. Stilgenbauer
|
8 |
2008 |
8
🐜
|
|
🐜
|
Cellular origin and pathophysiology of chronic lymphocytic leukemia
7 auth.
M. Seifert,
L. Sellmann,
J. Bloehdorn,
F. Wein,
S. Stilgenbauer,
J. Dürig,
...
R. Küppers
|
8 |
2012 |
8
🐜
|
|
🐜
|
Tumor-derived exosomes modulate PD-L1 expression in monocytes
21 auth.
Franziska Haderk,
R. Schulz,
M. Iskar,
Laura Llaó Cid,
T. Worst,
Karolin V Willmund,
A. Schulz,
U. Warnken,
J. Seiler,
A. Benner,
...
M. Nessling,
T. Zenz,
Maria Göbel,
J. Dürig,
S. Diederichs,
J. Paggetti,
E. Moussay,
S. Stilgenbauer,
M. Zapatka,
P. Lichter,
M. Seiffert
|
7 |
2017 |
7
🐜
|
|
🦁
|
ZAP-70 expression is a prognostic factor in chronic lymphocytic leukemia
9 auth.
J. Dürig,
H. Nückel,
M. Cremer,
Anja Führer,
K. Halfmeyer,
J. Fandrey,
...
T. Möröy,
L. Klein-Hitpass,
Ulrich Dührsen
|
7 |
2003 |
7
🦁
|
|
🐢
|
Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia
9 auth.
R. Schroers,
F. Griesinger,
L. Trümper,
D. Haase,
B. Kulle,
L. Klein-Hitpass,
...
L. Sellmann,
Ulrich Dührsen,
J. Dürig
|
7 |
2005 |
7
🐢
|
|
🦁
|
CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia
7 auth.
J. Dürig,
M. Naschar,
U. Schmücker,
K. Renzing-Köhler,
Tanja Hölter,
A. Hüttmann,
...
Ulrich Dührsen
|
7 |
2002 |
7
🦁
|
|
🐜
|
CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
7 auth.
S. Deaglio,
A. Capobianco,
L. Bergui,
J. Dürig,
F. Morabito,
U. Dührsen,
...
F. Malavasi
|
7 |
2003 |
7
🐜
|
|
🐜
|
Recurrent mutation of JAK3 in T‐cell prolymphocytic leukemia
17 auth.
A. Bergmann,
Sina Schneppenheim,
M. Seifert,
M. Betts,
A. Haake,
C. López,
Eva Maria Murga Penas,
I. Vater,
S. Jayne,
M. Dyer,
...
M. Schrappe,
U. Dührsen,
O. Ammerpohl,
R. Russell,
R. Küppers,
J. Dürig,
R. Siebert
|
7 |
2014 |
7
🐜
|
|
🐜
|
Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project
31 auth.
M. D'Agostino,
D. Cairns,
J. Lahuerta,
R. Wester,
U. Bertsch,
A. Waage,
E. Zamagni,
M. Mateos,
Daniele Dall’Olio,
N. V. D. van de Donk,
G. Jackson,
S. Rocchi,
H. Salwender,
Joan Bladé Creixenti,
B. van der Holt,
...
G. Castellani,
F. Bonello,
A. Capra,
E. Mai,
J. Dürig,
F. Gay,
S. Zweegman,
M. Cavo,
M. Kaiser,
H. Goldschmidt,
J. M. Hernández Rivas,
A. Larocca,
G. Cook,
J. San-Miguel,
M. Boccadoro,
P. Sonneveld
|
7 |
2022 |
7
🐜
|
|
🐜
|
Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas (PETAL): A Multicenter, Randomized Phase III Trial.
45 auth.
U. Dührsen,
S. Müller,
B. Hertenstein,
H. Thomssen,
J. Kotzerke,
R. Mesters,
W. Berdel,
C. Franzius,
F. Kroschinsky,
M. Weckesser,
D. Kofahl-Krause,
F. Bengel,
J. Dürig,
J. Matschke,
C. Schmitz,
...
T. Pöppel,
C. Ose,
M. Brinkmann,
P. La Rosée,
M. Freesmeyer,
A. Hertel,
H. Höffkes,
D. Behringer,
G. Prange‐Krex,
S. Wilop,
T. Krohn,
J. Holzinger,
M. Griesshammer,
Aristoteles A N Giagounidis,
A. Raghavachar,
G. Maschmeyer,
I. Brink,
H. Bernhard,
U. Haberkorn,
T. Gaska,
L. Kurch,
D. V. van Assema,
W. Klapper,
D. Hoelzer,
L. Geworski,
K. Jöckel,
A. Scherag,
A. Bockisch,
J. Rekowski,
A. Hüttmann
|
7 |
2018 |
7
🐜
|
|
🐬
|
HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia.
H. Nückel,
V. Rebmann,
J. Dürig,
U. Dührsen,
H. Grosse-wilde
|
7 |
2005 |
7
🐬
|
